Facts & Figures On Neurological Diseases In Europe
Main Category: Neurology / NeuroscienceAlso Included In: Parkinson's Disease; Epilepsy; Public Health
Article Date: 20 Jun 2007 - 0:00 PDT
| Patient / Public: | ![]() |
4 (2 votes) |
| Healthcare Prof: | ![]() |
5 (1 votes) |
In 2004 there were about 46 million cases of neurological diseases such as epilepsy, migraines, multiple sclerosis, Parkinson's disease and stroke among the 466 million inhabitants of the EU (excluding the two new members Romania and Bulgaria, but including the non-members Iceland, Norway and Switzerland). According to a study entitled "Costs of Disorders of the Brain in Europe" (European Journal of Neurology, Volume 12, Supplement 1, June 2005), a further five million people suffered from dementia, a disease classified both as a neurological and a mental disorder.
Costs of the Various Kinds of Neurological Disorders
Neurological diseases incur costs of €84 billion a year. Migraines account for about €27 billion of the total, strokes for about €22 billion, epilepsy for about €15.5 billion, Parkinson's for about €10.5 billion and multiple sclerosis for about €9 billion. According to the authors of the study, however, these figures are probably much higher, especially for strokes. There was too little precise data available on the frequency and costs of strokes. Dementia, for its part, is associated with financial outlays of €55 billion.
Provision of Neurological Care
Data on neurological care can be found in the Neurology Atlas of the World Health Organization (WHO) for 2004. This survey reference work indicates that Europe has by far the best supply of neurological health care services of the six WHO regions. There are 4.84 neurologists per 100,000 inhabitants in the European countries compared with only 0.03 for Africa. The United States has more than five neurologists per 100,000 inhabitants. For North and South America as a whole, however, the average is only 0.89 neurologist per 100,000 inhabitants.
Cost of Disorders of the Brain and the Nervous System as a Whole
If the cost of disorders of the brain and nervous system are viewed as a whole, one has to add to the €84 billion figure for neurological disorders and the €55 billion for dementia an additional amount of about €239.5 billion for mental disorders. Mental disorders include addictions, anxiety disorders, and psychoses as well as affective psychoses such as depression and bipolar disorders. About €7.5 billion is spent on neurosurgical disorders such as brain tumors and brain injuries. That adds up to a total of €386 billion for 127 million cases for the 466 million inhabitants of the EU 25 plus Iceland, Norway and Switzerland. According to WHO data and the study "Costs of Disorders of the Brain in Europe", disorders of the brain and the nervous system account for no less than 35 percent of the total health care burden in Europe. Nonetheless, they are not given the same attention as cardio-vascular disease, cancer or AIDS. Since the study was able to deal with only the most common disorders and not all countries covered had sufficient data available, the authors believe the actual cost to the economy is more on the order of €500 to €700 billion.
Direct and Indirect Costs
Of the estimated €386 billion, €135 billion are allocable to direct medical costs, which in turn can be broken down into stationary care (€78 billion), out-patient care (€45 billion) and drug therapy (€13 billion). The indirect costs include lost workdays and productivity losses and are estimated at €179 billion. The direct non-medical costs include money spent on social services and nursing care and amount to an estimated €72 billion.
Costs per Case
The per-case costs vary greatly with country and type of disorder. For migraine patients, for example, the per-case costs range from €133 in Estonia to €1,030 in Switzerland and for patients with brain tumors, from €9,375 in Estonia to €67,841 in Switzerland.
B&K KOMMUNIKATION
Porzellangasse 35
http://www.bkkommunikation.at
Visit our neurology / neuroscience section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/74724.php>
APA
http://www.medicalnewstoday.com/releases/74724.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




